Galantos Pharma Raises €4 Million
Galantos Pharma, a German drug company focused on Alzheimer's Dementia, has raised €4.4 million in Series C funding. Backers include VRP (Rhineland Palatinate Fund), KfW (German State Bank), FIB (Investment Bank Rhineland Palatinate), WFT (Venture Fund Rhineland Palatinate), HTGF (High-Tech Fund) and the BMBF (German Ministry for Education and Research).
4 May 2010•2 mins read
